You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The deal marks the 10th distribution agreement Australia-based Sienna has signed for its test, including one covering Finland earlier this year.
NG Biotech's COVID-19 NG-Test IgG-IgM test detects and differentiates the presence of isotypes IgG and IgG antibodies to SARS-CoV-2.
SG Blocks said it intends to create SARS-CoV-2 testing facilities using its expertise in building structures from maritime-grade shipping containers.
The new distribution partnership is for the US acute care market where, until now, Spartan was selling directly.
Last month, Quest Diagnostics received Emergency Use Authorization from the US Food and Drug Administration for its SARS-CoV-2 rRT PCR test.
Aytu has committed to purchasing at least 1.25 million tests within the first three months of the deal, including 500,000 tests immediately.
The agreement reflects Oncocyte's strategy to establish distribution partners with existing oncology channels to extend the reach of its tests globally.
United said it will distribute the test to international governments and healthcare organizations.
Credo Diagnostics recently received the CE mark for the coronavirus test, which can provide results in 20 minutes.
The point-of-care test is designed to detect SARS-CoV-2 antibodies in blood, serum, or plasma, with results available within 15 minutes.